Singapore Enteral feeding is a method of delivering nutrition or
medications directly in the stomach or intestine, and is usually recommended
for patients suffering from chronic illnesses such as head & neck cancer,
dementia and stroke. Increasing incidence of cancer and neurological diseases,
growing awareness of enteral feeding and rising adoption of home and hospital
enteral feeding devices would considerably drive the Singapore market growth.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝
𝐒𝐚𝐦𝐩𝐥𝐞
𝐑𝐞𝐩𝐨𝐫𝐭
https://www.alliedmarketresearch.com/request-sample/704
In 2014, Singapore neurological application was the leading segment in
the enteral feeding application market mainly due to the established use of
enteral feeding devices in CNS and mental health disorders. However, by 2020,
cancer is expected to takeover Singapore neurological application owing to increasing
adoption of enteral nutrition among cancer patients and faster rise in cancer
patients.
North America held a dominant position in the Singapore enteral
feeding device market in 2014, and is expected to maintain its lead throughout
the forecast period. This is mainly due to high per capita spending on clinical
nutrition, and well established reimbursement scenario. Europe is the second
leading geography due to increasing popularity of enteral feeding among adults
and pediatrics and high clinical spending in countries such as Spain, France,
Germany and United Kingdom. However, the Asia-Pacific region is estimated to
register the fastest growth due to growing awareness of enteral nutrition and
increasing disposable income in countries like China and India.
The key companies profiled in this report include, Medtronic
plc, Fresenius SE & Co. KGaA, Halyard Health, Inc., Boston Scientific
Corporation, Danone, Nestl S.A., Moog, Inc., B. Braun Melsungen AG, C. R. Bard,
Inc. and CONMED Corporation.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱
𝐑𝐞𝐩𝐨𝐫𝐭
https://www.alliedmarketresearch.com/enteral-feeding-devices-market
0 Comments